Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified NK-92 cells for treating cancer

Modified NK-92 cells for treating cancer

US Patent 10738279 · Granted Aug 11, 2020

Estimated economic value: $20,924,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for treating SARS and treating or preventing ARDS2025
Genetically modified NK-92 cells having a safety switch2025
Oral pharmaceutical formulations of bitter compounds for pulmonary hypertension2025
Oral pharmaceutical formulations of bitter compounds for asthma2025
Modified NK-92 cells for treating cancer2023
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of 2021
Use of nanoparticles coated with red blood cell membranes to treat hemolytic dis2021
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of 2021
Oral pharmaceutical formulation for weight loss, diabetes and related disorders2020
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of 2020
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of 2019
Use of nanoparticles coated with red blood cell membranes to enable blood transf2019